[Diagnosis and treatment strategies of hepatitis C-related hepatocellular carcinoma in the era of direct-acting antiviral drugs].

Gao, X; Ji, F P

Gao, X; Ji, F P.

Affiliation

Gao X; Department of Infectious Disease, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China.
Ji FP; Department of Infectious Disease, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China.

Zhonghua Gan Zang Bing Za Zhi ; 28(10): 827-830, 2020 Oct 20.

Article in Zh | MEDLINE | ID: mdl-33105926

Subject(s)

Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis C, Chronic; Liver Neoplasms; Antiviral Agents/therapeutic use; Carcinoma, Hepatocellular/diagnosis; Carcinoma, Hepatocellular/drug therapy; Carcinoma, Hepatocellular/virology; Hepatitis C, Chronic/complications; Hepatitis C, Chronic/drug therapy; Humans; Liver Cirrhosis/drug therapy; Liver Cirrhosis/virology; Liver Neoplasms/diagnosis; Liver Neoplasms/drug therapy; Liver Neoplasms/virology

Key words

Chronic hepatitis C; Diagnosis and treatment strategy; Direct-acting antiviral agents; Hepatocellular carcinoma

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Antiviral Agents / Carcinoma, Hepatocellular / Hepatitis C, Chronic / Liver Neoplasms Type of study: Diagnostic_studies Limits: Humans Language: Zh Year: 2020 Type: Article

Fulltext

XML

PubMed Links

Search on Google